Hyperplastic/serrated polyposis syndrome (HPS) is a condition characterized by multiple hyperplastic/serrated colorectal polyps. The risk of colorectal cancer (CRC) is increased in HPS. The clinicopathologic characteristics of HPS in Japanese patients are unknown.

The aim of this study is to clarify the clinicopathologic features of HPS in Japanese patients.

Methods

We retrieved records of patients diagnosed with HPS between April 2008 and March 2011 from the endoscopy database of Hiroshima University Hospital. In addition, we mailed a questionnaire to the hospital's 13 affiliated hospitals in July 2012. Data collected from the database and questionnaires included patient age, sex, number of hyperplastic/serrated polyps and tubular adenomas, size of the largest polyp, polyp location, resection for polyps, coexistence of HPS with CRC, and the diagnostic criterion met.

Results

Of the 73 608 patients who underwent colonoscopy, 10 (0.014%) met the criteria for HPS. The mean age of these patients was 58.3 years, and 6 (60%) were men. No subjects had a first-degree relative with HPS. Four (40%) HPS patients had more than 30 hyperplastic/serrated polyps, and average size of the largest polyp was 19 mm. Three (30%) HPS patients had coexistence of HPS with CRC. In these 3 patients, polyps were observed throughout the colorectum.

Conclusions

Although HPS was a rare condition in the overall study population, patients with the disease may have high risk of CRC. HPS should be diagnosed correctly and followed up carefully.

References

1 Boparai KS, Mathus-Vliegen EM, Koornstra JJ et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010; 59: 1094–1100.
10.1136/gut.2009.185884
PubMed Web of Science® Google Scholar
2 Boparai KS, Reitsma JB, Lemmens V et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010; 59: 1222–1225.
10.1136/gut.2009.200741
CAS PubMed Web of Science® Google Scholar
3 Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138: 2088–2100.
10.1053/j.gastro.2009.12.066
CAS PubMed Web of Science® Google Scholar
4 Kambara T, Simms LA, Whitehall VL et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004; 53: 1137–1144.
10.1136/gut.2003.037671
CAS PubMed Web of Science® Google Scholar
5 Young J, Barker MA, Simms LA et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin. Gastroenterol. Hepatol. 2005; 3: 254–263.
10.1016/S1542-3565(04)00673-1
CAS PubMed Web of Science® Google Scholar
6 Jass JR, Iino H, Ruszkiewicz A et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 2000; 47: 43–49.
10.1136/gut.47.1.43
CAS PubMed Web of Science® Google Scholar
7 Snover DC, Ahnen DJ, Burt RW et al. Serrated polyps of the colon and rectum and serrated polyposis. In: FT Bosman, F Carneiro, RH Hruban et al., eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC Press, 2010; 160–165.
Google Scholar
8 Oba S, Tanaka S, Oka S et al. Characterization of colorectal tumors using narrow-band imaging magnification: combined diagnosis with both pit pattern and microvessel features. Scand. J. Gastroenterol. 2010; 45: 1084–1092.
10.3109/00365521003734166
PubMed Web of Science® Google Scholar
9 Kudo S, Hirota S, Nakajima T et al. Colorectal tumours and pit pattern. J. Clin. Pathol. 1994; 47: 880–885.
10.1136/jcp.47.10.880
CAS PubMed Web of Science® Google Scholar
10 Snover DC, Jass JR, Fenoglio-Preiser C et al. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am. J. Clin. Pathol. 2005; 124: 380–391.
10.1309/V2EPTPLJRB3FGHJL
PubMed Web of Science® Google Scholar
11 Torlakovic E, Skovlund E, Snover DC et al. Morphologic reappraisal of serrated colorectal polyps. Am. J. Surg. Pathol. 2003; 27: 65–81.
10.1097/00000478-200301000-00008
PubMed Web of Science® Google Scholar
12 Tuppurainen K, Makinen JM, Junttila O et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J. Pathol. 2005; 207: 285–294.
10.1002/path.1850
CAS PubMed Web of Science® Google Scholar
13 Rosty C, Buchanan DD, Walsh MD et al. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am. J. Surg. Pathol. 2012; 36: 876–882.
10.1097/PAS.0b013e31824e133f
PubMed Web of Science® Google Scholar
14 Edelstein DL, Axilbund JE, Hylind LM et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut 2013; 62: 404–408.
10.1136/gutjnl-2011-300514
PubMed Web of Science® Google Scholar
15 Hassan C, Pickhardt PJ, Kim DH et al. Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment. Pharmacol. Ther. 2010; 31: 210–217.
10.1111/j.1365-2036.2009.04160.x
CAS PubMed Web of Science® Google Scholar
16 Lage P, Cravo M, Sousa R et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am. J. Gastroenterol. 2004; 99: 1779–1784.
10.1111/j.1572-0241.2004.30178.x
CAS PubMed Web of Science® Google Scholar
17 Rashid A, Houlihan PS, Booker S et al. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000; 119: 323–332.
10.1053/gast.2000.9361
CAS PubMed Web of Science® Google Scholar
18 Orlowska J, Kiedroeski M, Kaminski FM et al. Hyperplastic polyposis syndrome in asymptomatic patients: the results from the colorectal-cancer screening program. Virchows Arch. 2009; 455 (Suppl. 1): S47.
Google Scholar
19 Lockett M, Atkin WS. Hyperplastic polyposis (HPP): prevalence and cancer risk. Gut 2001; 49 (Suppl. 1): A4.
Google Scholar
20 Krishna C, Rex DK. Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps. Gastrointest. Endosc. 2012; 75: 1206–1210.
10.1016/j.gie.2012.01.033
PubMed Web of Science® Google Scholar
21 Biswas S, Ellis AJ, Guy R et al. High prevalence of hyperplastic polyposis syndrome (serrated polyposis) in the NHS bowel cancer screening programme. Gut 2013; 62: 475.
10.1136/gutjnl-2012-303233
PubMed Web of Science® Google Scholar
22 Moreira L, Pellisé M, Carballal S et al. High prevalence of serrated polyposis syndrome in FIT-based colorectal cancer screening programmes. Gut 2013; 62: 476–477.
10.1136/gutjnl-2012-303496
PubMed Web of Science® Google Scholar
23 Hiraoka S, Kato J, Fujiki S et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology 2010; 139: 1503–1510.
10.1053/j.gastro.2010.07.011
PubMed Web of Science® Google Scholar
24 Chow E, Lipton L, Lynch E et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006; 131: 30–39.
10.1053/j.gastro.2006.03.046
CAS PubMed Web of Science® Google Scholar
25 Guarinos C, Sánchez-Fortún C, Rodríguez-Soler M et al. Serrated polyposis syndrome: molecular, pathological and clinical aspects. World J. Gastroenterol. 2012; 18: 2452–2461.
10.3748/wjg.v18.i20.2452
CAS PubMed Web of Science® Google Scholar
26 Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949–954.
10.1038/nature00766
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume28, Issue11

November 2013

Pages 1693-1698

Clinicopathologic features of hyperplastic/serrated polyposis syndrome in Japan

Abstract

Background and Aim

Methods

Results

Conclusions

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Clinicopathologic features of hyperplastic/serrated polyposis syndrome in Japan

Abstract

Background and Aim

Methods

Results

Conclusions

References

Citing Literature

References

Related

Information